Scienture Holdings, Inc. Files 8-K for Material Agreement
Ticker: SCNX · Form: 8-K · Filed: Sep 23, 2025 · CIK: 1382574
| Field | Detail |
|---|---|
| Company | Scienture Holdings, Inc. (SCNX) |
| Form Type | 8-K |
| Filed Date | Sep 23, 2025 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.00001, $9,200,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, 8-K, corporate-actions
TL;DR
Scienture Holdings (SCT) filed an 8-K for a new material agreement, check for details.
AI Summary
On September 19, 2025, Scienture Holdings, Inc. entered into a material definitive agreement. The filing also includes financial statements and exhibits. The company, formerly known as TRxADE HEALTH, INC., is incorporated in Delaware and headquartered in Commack, NY.
Why It Matters
This 8-K filing indicates a significant new agreement for Scienture Holdings, Inc., which could impact its future business operations and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood.
Key Players & Entities
- Scienture Holdings, Inc. (company) — Registrant
- TRxADE HEALTH, INC. (company) — Former company name
- September 19, 2025 (date) — Date of earliest event reported
- 20 Austin Blvd. Commack, NY 11725 (address) — Principal Executive Offices
- 001-39199 (other) — Commission File Number
FAQ
What is the nature of the material definitive agreement entered into by Scienture Holdings, Inc. on September 19, 2025?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the provided text.
What were Scienture Holdings, Inc.'s previous names?
Scienture Holdings, Inc. was formerly known as TRxADE HEALTH, INC. and TRXADE GROUP, INC., and XCELLINK INTERNATIONAL INC.
Where is Scienture Holdings, Inc. headquartered?
Scienture Holdings, Inc. is headquartered at 20 Austin Blvd., Commack, NY 11725.
What is the SIC code for Scienture Holdings, Inc.?
The Standard Industrial Classification (SIC) code for Scienture Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
When was the company incorporated?
The company was incorporated in Delaware.
Filing Stats: 1,110 words · 4 min read · ~4 pages · Grade level 11.1 · Accepted 2025-09-23 17:01:18
Key Financial Figures
- $0.00001 — ch registered Common Stock, par value $0.00001 per share SCNX The Nasdaq Stock Mar
- $9,200,000 — an aggregate gross sales price of up to $9,200,000 (the " Shares "), which is based on the
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex1-1.htm (EX-1.1) — 28KB
- ex5-1.htm (EX-5.1) — 15KB
- ex1-1_001.jpg (GRAPHIC) — 445KB
- ex1-1_002.jpg (GRAPHIC) — 566KB
- ex1-1_003.jpg (GRAPHIC) — 782KB
- ex1-1_004.jpg (GRAPHIC) — 811KB
- ex1-1_005.jpg (GRAPHIC) — 867KB
- ex1-1_006.jpg (GRAPHIC) — 853KB
- ex1-1_007.jpg (GRAPHIC) — 897KB
- ex1-1_008.jpg (GRAPHIC) — 910KB
- ex1-1_009.jpg (GRAPHIC) — 902KB
- ex1-1_010.jpg (GRAPHIC) — 914KB
- ex1-1_011.jpg (GRAPHIC) — 888KB
- ex1-1_012.jpg (GRAPHIC) — 911KB
- ex1-1_013.jpg (GRAPHIC) — 903KB
- ex1-1_014.jpg (GRAPHIC) — 875KB
- ex1-1_015.jpg (GRAPHIC) — 951KB
- ex1-1_016.jpg (GRAPHIC) — 919KB
- ex1-1_017.jpg (GRAPHIC) — 876KB
- ex1-1_018.jpg (GRAPHIC) — 875KB
- ex1-1_019.jpg (GRAPHIC) — 900KB
- ex1-1_020.jpg (GRAPHIC) — 834KB
- ex1-1_021.jpg (GRAPHIC) — 871KB
- ex1-1_022.jpg (GRAPHIC) — 822KB
- ex1-1_023.jpg (GRAPHIC) — 768KB
- ex1-1_024.jpg (GRAPHIC) — 956KB
- ex1-1_025.jpg (GRAPHIC) — 862KB
- ex1-1_026.jpg (GRAPHIC) — 841KB
- ex1-1_027.jpg (GRAPHIC) — 642KB
- ex1-1_028.jpg (GRAPHIC) — 260KB
- ex1-1_029.jpg (GRAPHIC) — 233KB
- ex1-1_030.jpg (GRAPHIC) — 559KB
- ex5-1_001.jpg (GRAPHIC) — 6KB
- 0001493152-25-014658.txt ( ) — 32873KB
- scnx-20250919.xsd (EX-101.SCH) — 3KB
- scnx-20250919_lab.xml (EX-101.LAB) — 33KB
- scnx-20250919_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCIENTURE HOLDINGS, INC. By: /s/ Dr. Narasimhan Mani Dr. Narasimhan Mani Co-Chief Executive Officer Date: September 23, 2025